IMMUNOLOGY CORE LAB
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsIf you are putting fresh money into the stock market (or even looking to rejig your existing portfolio), it would be best not to react to w...
Fresh tailwinds emerge as government comes in again with intent: 7 pharma stocks with upside potential of up to 36%Budget 2026 underlines the government’s intent – in terms of the sectors it will focus on. Now, it is not all of a sudden that the governme...
India destined to be global leader in science: Jitendra SinghSingh also referred to Prime Minister Narendra Modi's personal indulgence in promoting every pursuit in the field of science. The union min...
Indian pharma industry capable of discovering new drugs, says Sun Pharma's Dilip ShanghviHe, however, cautioned that the industry should gear up to strengthen the core areas such as clinical development and research capabilities.
Load More